Unknown

Dataset Information

0

Activity of Brigatinib in Crizotinib and Ceritinib-Resistant ROS1- Rearranged Non-Small-Cell Lung Cancer.

ABSTRACT:

SUBMITTER: Hegde A 

PROVIDER: S-EPMC7410165 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Crizotinib in ROS1-rearranged non-small-cell lung cancer.
| S-EPMC4264527 | biostudies-other
Unknown Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case report.
| S-EPMC8590892 | biostudies-literature
Unknown The role of brigatinib in crizotinib-resistant non-small cell lung cancer.
| S-EPMC5783011 | biostudies-literature
Unknown Ceritinib in ALK-rearranged non-small-cell lung cancer.
| S-EPMC4079055 | biostudies-literature
Unknown Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyond.
| S-EPMC4408973 | biostudies-literature
Unknown First-line crizotinib versus platinum-pemetrexed chemotherapy in patients with advanced ROS1-rearranged non-small-cell lung cancer.
| S-EPMC7221427 | biostudies-literature
Unknown Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
| S-EPMC6637370 | biostudies-literature
Unknown Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma.
| S-EPMC6794186 | biostudies-literature
Unknown Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer.
| S-EPMC7066105 | biostudies-literature
Unknown The ALK inhibitor ceritinib overcomes crizotinib resistance in non-small cell lung cancer.
| S-EPMC4068971 | biostudies-literature